Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists.
Wu M, Carballo-Jane E, Zhou H, Zafian P, Dai G, Liu M, Lao J, Kelly T, Shao D, Gorski J, Pissarnitski D, Kekec A, Chen Y, Previs SF, Scapin G, Gomez-Llorente Y, Hollingsworth SA, Yan L, Feng D, Huo P, Walford G, Erion MD, Kelley DE, Lin S, Mu J.
Wu M, et al. Among authors: kelley de.
Nat Commun. 2024 Jan 23;15(1):688. doi: 10.1038/s41467-024-44938-4.
Nat Commun. 2024.
PMID: 38263326
Free PMC article.
No abstract available.